Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Effects of Time and Storage Conditions on the Chemical and Microbiologic Stability of Diluted Buprenorphine for Injection.

DenHerder JM, Reed RL, Sargent JL, Bobe G, Stevens JF, Diggs HE.

J Am Assoc Lab Anim Sci. 2017 Jul 1;56(4):457-461.

2.
3.

Room temperature housing results in premature cancellous bone loss in growing female mice: implications for the mouse as a preclinical model for age-related bone loss.

Iwaniec UT, Philbrick KA, Wong CP, Gordon JL, Kahler-Quesada AM, Olson DA, Branscum AJ, Sargent JL, DeMambro VE, Rosen CJ, Turner RT.

Osteoporos Int. 2016 Oct;27(10):3091-101. doi: 10.1007/s00198-016-3634-3. Epub 2016 May 17.

4.

Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics.

Sargent JL, Li Z, Aliprantis AO, Greenblatt M, Lemaire R, Wu MH, Wei J, Taroni J, Harris A, Long KB, Burgwin C, Artlett CM, Blankenhorn EP, Lafyatis R, Varga J, Clark SH, Whitfield ML.

Arthritis Rheumatol. 2016 Aug;68(8):2003-15. doi: 10.1002/art.39658.

5.
6.

Characterization of Train-Induced Vibration and its Effect on Fecal Corticosterone Metabolites in Mice.

Atanasov NA, Sargent JL, Parmigiani JP, Palme R, Diggs HE.

J Am Assoc Lab Anim Sci. 2015 Nov;54(6):737-44.

7.

Experimentally-derived fibroblast gene signatures identify molecular pathways associated with distinct subsets of systemic sclerosis patients in three independent cohorts.

Johnson ME, Mahoney JM, Taroni J, Sargent JL, Marmarelis E, Wu MR, Varga J, Hinchcliff ME, Whitfield ML.

PLoS One. 2015 Jan 21;10(1):e0114017. doi: 10.1371/journal.pone.0114017. eCollection 2015.

8.

Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determined.

Dillahunt SE, Sargent JL, Suzuki R, Proia RL, Gilfillan A, Rivera J, Olivera A.

J Immunol. 2013 Mar 1;190(5):2058-67. doi: 10.4049/jimmunol.1201503. Epub 2013 Jan 28.

9.

Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells.

Wei J, Fang F, Lam AP, Sargent JL, Hamburg E, Hinchcliff ME, Gottardi CJ, Atit R, Whitfield ML, Varga J.

Arthritis Rheum. 2012 Aug;64(8):2734-45. doi: 10.1002/art.34424.

10.

Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets.

Greenblatt MB, Sargent JL, Farina G, Tsang K, Lafyatis R, Glimcher LH, Whitfield ML, Aliprantis AO.

Am J Pathol. 2012 Mar;180(3):1080-94. doi: 10.1016/j.ajpath.2011.11.024. Epub 2012 Jan 11.

11.

Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis.

Hershko AY, Suzuki R, Charles N, Alvarez-Errico D, Sargent JL, Laurence A, Rivera J.

Immunity. 2011 Oct 28;35(4):562-71. doi: 10.1016/j.immuni.2011.07.013. Epub 2011 Oct 6.

12.

Egr-1 induces a profibrotic injury/repair gene program associated with systemic sclerosis.

Bhattacharyya S, Sargent JL, Du P, Lin S, Tourtellotte WG, Takehara K, Whitfield ML, Varga J.

PLoS One. 2011;6(9):e23082. doi: 10.1371/journal.pone.0023082. Epub 2011 Sep 13.

13.

PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeability.

Furumoto Y, Charles N, Olivera A, Leung WH, Dillahunt S, Sargent JL, Tinsley K, Odom S, Scott E, Wilson TM, Ghoreschi K, Kneilling M, Chen M, Lee DM, Bolland S, Rivera J.

Blood. 2011 Nov 17;118(20):5466-75. doi: 10.1182/blood-2010-09-309955. Epub 2011 Sep 16.

14.

Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling.

Sargent JL, Whitfield ML.

Expert Rev Clin Immunol. 2011 Jul;7(4):463-73. doi: 10.1586/eci.11.41. Review.

15.

PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis.

Wei J, Ghosh AK, Sargent JL, Komura K, Wu M, Huang QQ, Jain M, Whitfield ML, Feghali-Bostwick C, Varga J.

PLoS One. 2010 Nov 2;5(11):e13778. doi: 10.1371/journal.pone.0013778.

16.

A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity.

Sargent JL, Milano A, Bhattacharyya S, Varga J, Connolly MK, Chang HY, Whitfield ML.

J Invest Dermatol. 2010 Mar;130(3):694-705. doi: 10.1038/jid.2009.318. Epub 2009 Oct 8.

17.

The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitis.

Milks MW, Cripps JG, Lin H, Wang J, Robinson RT, Sargent JL, Whitfield ML, Gorham JD.

Liver Int. 2009 Oct;29(9):1307-15. doi: 10.1111/j.1478-3231.2009.02028.x. Epub 2009 Apr 16.

18.

Molecular subsets in the gene expression signatures of scleroderma skin.

Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, Connolly MK, Whitfield ML.

PLoS One. 2008 Jul 16;3(7):e2696. doi: 10.1371/journal.pone.0002696. Erratum in: PLoS ONE. 2008;3(10). doi: 10.1371/annotation/05bed72c-c6f6-4685-a732-02c78e5f66c2.

19.

Scleroderma gene expression and pathway signatures.

Sargent JL, Milano A, Connolly MK, Whitfield ML.

Curr Rheumatol Rep. 2008 Jul;10(3):205-11. Review.

PMID:
18638428
20.

Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces.

Shanks RM, Sargent JL, Martinez RM, Graber ML, O'Toole GA.

Nephrol Dial Transplant. 2006 Aug;21(8):2247-55. Epub 2006 Apr 20.

PMID:
16627606
21.

Pseudomonas aeruginosa fimL regulates multiple virulence functions by intersecting with Vfr-modulated pathways.

Whitchurch CB, Beatson SA, Comolli JC, Jakobsen T, Sargent JL, Bertrand JJ, West J, Klausen M, Waite LL, Kang PJ, Tolker-Nielsen T, Mattick JS, Engel JN.

Mol Microbiol. 2005 Mar;55(5):1357-78.

22.

Characterization of a complex chemosensory signal transduction system which controls twitching motility in Pseudomonas aeruginosa.

Whitchurch CB, Leech AJ, Young MD, Kennedy D, Sargent JL, Bertrand JJ, Semmler AB, Mellick AS, Martin PR, Alm RA, Hobbs M, Beatson SA, Huang B, Nguyen L, Commolli JC, Engel JN, Darzins A, Mattick JS.

Mol Microbiol. 2004 May;52(3):873-93.

23.

Phosphorylation of the Pseudomonas aeruginosa response regulator AlgR is essential for type IV fimbria-mediated twitching motility.

Whitchurch CB, Erova TE, Emery JA, Sargent JL, Harris JM, Semmler AB, Young MD, Mattick JS, Wozniak DJ.

J Bacteriol. 2002 Aug;184(16):4544-54.

24.

Differential regulation of twitching motility and elastase production by Vfr in Pseudomonas aeruginosa.

Beatson SA, Whitchurch CB, Sargent JL, Levesque RC, Mattick JS.

J Bacteriol. 2002 Jul;184(13):3605-13.

Supplemental Content

Loading ...
Support Center